Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
64.47
-2.01
(-3.02%)
Streaming Delayed Price
Updated: 12:00 PM EDT, Mar 12, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 420,112 |
| Open | 65.38 |
| Bid (Size) | 64.40 (1,500) |
| Ask (Size) | 64.54 (200) |
| Prev. Close | 66.48 |
| Today's Range | 64.35 - 66.32 |
| 52wk Range | 47.50 - 82.22 |
| Shares Outstanding | 142,334,900 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
| YTD |
-8.3%
|
-8.3%
|
| 1 Month |
-19.9%
|
-19.9%
|
| 3 Month |
+2.9%
|
+2.9%
|
| 6 Month |
-14.9%
|
-14.9%
|
| 1 Year |
+4.9%
|
+4.9%
|
More News
Read More
Halozyme (HALO) Q4 2025 Earnings Call Transcript ↗
February 17, 2026
Via The Motley Fool
Topics
Earnings
Halozyme Therapeutics (NASDAQ:HALO) Surprises With Q4 CY2025 Sales
February 17, 2026
Via StockStory
3 Small-Cap Stocks with Solid Fundamentals
February 08, 2026
Via StockStory
Topics
Government
3 Growth Stocks Set to Flourish
February 01, 2026
Via StockStory
Q3 Earnings Highs And Lows: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
January 28, 2026
Via StockStory
Topics
Artificial Intelligence
Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)
January 27, 2026
Via StockStory
Topics
Artificial Intelligence
Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks
January 25, 2026
Via StockStory
Topics
Artificial Intelligence
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
January 24, 2026
Via The Motley Fool
Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)
January 21, 2026
Via StockStory
Topics
Artificial Intelligence
Via The Motley Fool
Via StockStory
Topics
Artificial Intelligence
1 Surging Stock Worth Investigating and 2 We Brush Off
January 11, 2026
Via StockStory
Halozyme Therapeutics (HALO): Buy, Sell, or Hold Post Q3 Earnings?
January 07, 2026
Via StockStory
Topics
Stocks
Frequently Asked Questions
Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 64.47
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 03/12/26 12:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.18B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>